Rinvoq ER 45 MG tablet UU 28S
Ended Awarded Last action
- Contract number
- SPE2DR26F9Q51
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $92,281
Award facts
- Contract value 100% obligated
- $92,281.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $92,281.33 to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-count units) on December 17, 2025, with completion targeted for December 18, 2025. This firm fixed-price delivery order represents a non-competitive award executed under a larger contract vehicle and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. RINVOQ (upadacitinib) is a Janus kinase (JAK) inhibitor used to treat rheumatoid arthritis and other inflammatory conditions, supporting military and federal healthcare system pharmaceutical supply needs.
This delivery order is a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to meet federal procurement requirements and serves critical customers including the Defense Health Agency and U.S. Coast Guard through competitively awarded contracts with flexible pricing structures.
Quick answers
Who was awarded contract SPE2DR26F9Q51?
SPE2DR26F9Q51 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26F9Q51 worth?
The government has obligated $92,281 on SPE2DR26F9Q51.
Is contract SPE2DR26F9Q51 an order under another contract?
Yes. SPE2DR26F9Q51 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9Q51 competed?
The extent of competition for SPE2DR26F9Q51 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award